As our understanding of HFpEF evolves, GLP-1RAs have the potential to become a cornerstone of therapy, addressing the multifactorial nature of this condition and improving outcomes in a challenging patient population
Insurance Coverage and Self-Pay Options Insurance coverage for GLP-1 medications varies by plan
Andersen, N.B., et al., The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats
Enhances skin brightness and reduces pigmentation
Approved indications Tresiba is approved for type 1 diabetes and type 2 diabetes
Lugrin, J., et al., The role of oxidative stress during inflammatory processes